Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
Clinical trial NCT05739435 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05739435
- Sponsor
- Alumis Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2027-12-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.